ArticleScientific reports2025
The mediating role of resilience in the relationship between empowerment and benefit finding among Chinese colorectal cancer patients.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
This study aimed to assess the resilience, empowerment, and benefit finding of colorectal cancer patients in China and to examine the mediating role of resilience in the relationship between empowerment and benefit finding. Three hundred and eleven colorectal cancer patients were recruited from January to July 2023. The questionnaire included a general information questionnaire, a resilience scale (CD-RISC-10), a Chinese cancer empowerment questionnaire (CEQ), and a patient benefit finding scale (BFS). Structural equation models were used to evaluate whether resilience was a mediator between empowerment and benefit finding. Our research found that colorectal cancer patients' resilience score was 19.408 ± 9.011, their empowerment score was 117.453 ± 32.995, and their benefit finding score was 65.752 ± 18.756. Empowerment was positively correlated with resilience (r = 0.116, p < 0.05), resilience was positively correlated with benefit finding (r = 0.187, p < 0.01), and empowerment was positively correlated with benefit finding (r = 0.22, p < 0.01). The fitness indices of the structural models were satisfactory. The indirect effect (a*b) of this pathway (empowerment > resilience > benefit finding) was 0.011 (95% CI 0.003 ~ 0.054). The total effect (c) of empowerment on benefit finding was 0.125 (0.063-0.187), and resilience plays a partial mediating role between empowerment and benefit finding, with the mediating effect (a*b/c) constituting 8.8%. Our research results show that most patients with colorectal cancer exhibit moderate levels of resilience. Resilience plays a partial mediating role in empowerment and benefit finding. Enhancing patients' resilience is one way to increase benefit finding.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.